370 related articles for article (PubMed ID: 35006557)
1. Pharmacological Management of Apathy in Dementia.
Azhar L; Kusumo RW; Marotta G; Lanctôt KL; Herrmann N
CNS Drugs; 2022 Feb; 36(2):143-165. PubMed ID: 35006557
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological interventions for apathy in Alzheimer's disease.
Ruthirakuhan MT; Herrmann N; Abraham EH; Chan S; Lanctôt KL
Cochrane Database Syst Rev; 2018 May; 5(5):CD012197. PubMed ID: 29727467
[TBL] [Abstract][Full Text] [Related]
3. A Systematic Review of Pharmacological Interventions for Apathy in Aging Neurocognitive Disorders.
Theleritis C; Siarkos K; Politis A; Smyrnis N; Papageorgiou C; Politis AM
Brain Sci; 2023 Jul; 13(7):. PubMed ID: 37508993
[TBL] [Abstract][Full Text] [Related]
4. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
Rolinski M; Fox C; Maidment I; McShane R
Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic treatments of dementia.
Bonner LT; Peskind ER
Med Clin North Am; 2002 May; 86(3):657-74. PubMed ID: 12171061
[TBL] [Abstract][Full Text] [Related]
6. Apathy in Dementia: Systematic Review of Recent Evidence on Pharmacological Treatments.
Harrison F; Aerts L; Brodaty H
Curr Psychiatry Rep; 2016 Nov; 18(11):103. PubMed ID: 27726067
[TBL] [Abstract][Full Text] [Related]
7. Prevalence, treatment, and neural correlates of apathy in different forms of dementia: a narrative review.
Parrotta I; Cacciatore S; D'Andrea F; D'Anna M; Giancaterino G; Lazzaro G; Arcara G; Manzo N
Neurol Sci; 2024 Apr; 45(4):1343-1376. PubMed ID: 38015288
[TBL] [Abstract][Full Text] [Related]
8. The Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): study protocol for a randomized controlled trial.
Scherer RW; Drye L; Mintzer J; Lanctôt K; Rosenberg P; Herrmann N; Padala P; Brawman-Mintzer O; Burke W; Craft S; Lerner AJ; Levey A; Porsteinsson A; van Dyck CH;
Trials; 2018 Jan; 19(1):46. PubMed ID: 29347996
[TBL] [Abstract][Full Text] [Related]
9. Frontotemporal dementia: recommendations for therapeutic studies, designs, and approaches.
Freedman M
Can J Neurol Sci; 2007 Mar; 34 Suppl 1():S118-24. PubMed ID: 17469694
[TBL] [Abstract][Full Text] [Related]
10. Clinical practice with anti-dementia drugs: A revised (third) consensus statement from the British Association for Psychopharmacology.
O'Brien JT; Holmes C; Jones M; Jones R; Livingston G; McKeith I; Mittler P; Passmore P; Ritchie C; Robinson L; Sampson EL; Taylor JP; Thomas A; Burns A
J Psychopharmacol; 2017 Feb; 31(2):147-168. PubMed ID: 28103749
[TBL] [Abstract][Full Text] [Related]
11. Cognitive performance in healthy clinical trial participants and patients with the NeuroCart, a neurodegenerative disease measured with an automated neuropsychological and neurophysiological test battery.
Prins S; Borghans L; de Kam ML; Groeneveld GJ; van Gerven J
J Neurol Sci; 2023 Jun; 449():120658. PubMed ID: 37079973
[TBL] [Abstract][Full Text] [Related]
12. Behavioral and Psychological Symptoms of Dementia in Different Dementia Disorders: A Large-Scale Study of 10,000 Individuals.
Schwertner E; Pereira JB; Xu H; Secnik J; Winblad B; Eriksdotter M; Nägga K; Religa D
J Alzheimers Dis; 2022; 87(3):1307-1318. PubMed ID: 35491774
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological treatment of apathy in Lewy body disorders: A systematic review.
Liu J; Cooper CA; Weintraub D; Dahodwala N
Parkinsonism Relat Disord; 2019 Mar; 60():14-24. PubMed ID: 30470658
[TBL] [Abstract][Full Text] [Related]
14. Clinical practice with anti-dementia drugs: a revised (second) consensus statement from the British Association for Psychopharmacology.
O'Brien JT; Burns A;
J Psychopharmacol; 2011 Aug; 25(8):997-1019. PubMed ID: 21088041
[TBL] [Abstract][Full Text] [Related]
15. Clinical practice with anti-dementia drugs: a consensus statement from British Association for Psychopharmacology.
Burns A; O'Brien J; ; Auriacombe S; Ballard C; Broich K; Bullock R; Feldman H; Ford G; Knapp M; McCaddon A; Iliffe S; Jacova C; Jones R; Lennon S; McKeith I; Orgogozo JM; Purandare N; Richardson M; Ritchie C; Thomas A; Warner J; Wilcock G; Wilkinson D;
J Psychopharmacol; 2006 Nov; 20(6):732-55. PubMed ID: 17060346
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological Therapy for Apathy in Alzheimer's Disease: A Systematic Review and Meta-Analysis.
Sepehry AA; Sarai M; Hsiung GR
Can J Neurol Sci; 2017 May; 44(3):267-275. PubMed ID: 28148339
[TBL] [Abstract][Full Text] [Related]
17. Apathy is associated with faster global cognitive decline and early nursing home admission in dementia with Lewy bodies.
Breitve MH; Brønnick K; Chwiszczuk LJ; Hynninen MJ; Aarsland D; Rongve A
Alzheimers Res Ther; 2018 Aug; 10(1):83. PubMed ID: 30121084
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
